The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2103-2107

  Dotzlaw, Helmut ^a   Leygue, Etienne ^a   Watson, Peter ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; GENE DELETION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032807743     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kliewer, S., Moore, J., Wade, L., Staudinger, J., Watson, M., Jones, S., McKee, D., Oliver, B., Willson, T., Zetterstrom, R., Perlmann, T., and Lehmann, J. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell, 92: 73-82, 1998.
2. Lehmann, J., McKee, D., Watson, M., Willson, T., Moore, J., and Kliewer, S. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest., 102: 1016-1023, 1998.
3. Mani, C., Gelboin, H., Park, S., Pearce, R., Parkinson, A., and Kupfer, D. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. 1. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Drug Metab. Dispos., 21: 645-656, 1993.
4. Berthou, F., Dreano, Y., Belloc, C., Kangas, L., Gautier, J-C., and Beaune, P. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochem. Pharmacol., 47: 1883-1895, 1994.
5. Mani, C., Pearce, R., Parkinson, A., and Kupfer, D. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis (Lond.), 15: 2715-2720, 1994.
6. Huang, Z., Fasco, M., Figge, H., Keyomarsi, K., and Kaminsky, L. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos., 24: 899-905, 1996.
7. Smith, G., Harrison, D., East, N., Rae, F., Wolf, H., and Wolf, C. Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts. Br. J. Cancer, 68: 57-63, 1993.
8. Hiller, T., Snell, L., and Watson, P. Microdissection/RT-PCR analysis of gene expression. Biotechniques, 21: 38-44, 1996.
9. Murphy, L., Lee-Wing, M., Goldenberg, G., and Shiu, R. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res., 47: 4160-4164, 1987.
10. Murphy, L. C., and Dotzlaw, H. Regulation of transforming growth factor alpha and transforming growth factor β messenger ribonucleic acid abundance in T-47D, human breast cancer cells. Mol. Endocrinol., 3: 611-617, 1989.
11. Dotzlaw, H., Leygue, E., Watson, P., and Murphy, L. Expression of estrogen receptor-β in human breast tumors. J. Clin. Endocrinol. Metab., 82: 2371-2374, 1997.
12. Nebert, D., and Gonzalez, F. P450 genes: structure, evolution and regulation. Annu. Rev. Biochem., 56: 945-993, 1987.
13. Juchau, M. Substrate specificities and functions of the P450 cytochromes. Life Sci., 47: 2385-2394, 1990.
14. Osborne, C., Coronado, E., Allred, D., Wiebe, V., and DeGregorio, M. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J. Natl. Cancer Inst., 83: 1477-1482, 1991.
15. Osborne, C., Wiebe, V., McGuire, W., Ciocca, D., and DeGregorio, M. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen resistant tumors from breast cancer patients. J. Clin. Oncol., 10: 304-310, 1992.
16. Goldberg, J., Plescia, M., and Anastasio, G. Mifepristone (RU 486): current knowledge and future prospects. Arch. Fam. Med., 7: 219-222, 1998.
17. Ravdin, P., Green, S., Dorr, T., McGuire, W., Fabian, C., Pugh, R., Carter, R., Rivkin, S., Borst, J., Belt, R., Metch, B., and Osborne, C. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J. Clin. Oncol., 10: 1284-1291, 1992.
18. Petersen, O. Frequency and distribution of estrogen receptor positive cells in normal non-lactating human breast. Cancer Res., 47: 5748-5751, 1987.